Background Carbapenemase-producing Enterobacterales isolates are associated with significant mortality and have emerged as a major problem in healthcare settings worldwide.
Amel Benbouza +6 more
doaj +1 more source
Emergence of OXA-484, an OXA-48–type beta-lactamase, in Switzerland
Jacqueline Findlay +3 more
doaj +1 more source
Emergence of OXA-48 Carbapenemase in Taiwan
Ma, Ling +8 more
openaire +1 more source
Activity of mecillinam against OXA-48-like carbapenemase-producing Enterobacterales
Tsakris, A. +3 more
openaire +3 more sources
Karbapenemaz üreten klebsıella spp. suşlarında oxa-48-lıke genlerinin araştırılması
78
openaire +2 more sources
Cefiderocol Comparative Resistance and Clinical Predictors in CRE-BSI: Data from an OXA-48-Endemic Region with Rising OXA-48/NDM Coproducers. [PDF]
Dumlu R, Mert A.
europepmc +1 more source
Phage-meropenem synergy against OXA-48-producing Klebsiella pneumoniae clinical isolates. [PDF]
Cantallops I +6 more
europepmc +1 more source
Carbapenem and colistin-resistant <i>Klebsiella pneumoniae</i> co-producing NDM-5 and OXA-48 in a teaching hospital from Tunisia. [PDF]
Jaidane N +14 more
europepmc +1 more source
Effects of phage-based treatments against an OXA-48-producing Klebsiella pneumoniae isolate in simulated human gut microbiomes. [PDF]
Ferriol-González C +7 more
europepmc +1 more source
Role of Giannella and Increment Scores to Predict OXA-48 Carbapenemase Producing Enterobacterales Infection and Mortality in Previous Rectal Carriers. [PDF]
Martínez Pérez-Crespo PM +16 more
europepmc +1 more source

